Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: A phase II, double-blind, randomized trial

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 3, 2011, Pages 1142-1147

  Cachovan, Georg ^a   Böger, Rainer H ^a   Giersdorf, Ina ^b   Hallier, Olaf ^c   Streichert, Thomas ^a   Haddad, Munif ^a   Platzer, Ursula ^a   Schön, Gerhard ^a   Wegscheider, Karl ^a   Sobottka, Ingo ^a,d  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Emergency Hospital Berlin   (Germany)

^c Deaconry Hospital Rotenburg   (Germany)

^d LADR GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; CLINDASTAD; MOXIFLOXACIN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADULT; AGED; AGGRESSION; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ASSESSMENT; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GINGIVA PAIN; GINGIVITIS; HUMAN; INFLAMMATORY INFILTRATE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TOOTH ABSCESS; TOOTH PAIN; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ABSCESS; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; CLINDAMYCIN; DOUBLE-BLIND METHOD; FEMALE; GINGIVITIS; HUMANS; MALE; MIDDLE AGED; NEUTROPHIL INFILTRATION; QUINOLINES; YOUNG ADULT;

EID: 79952321536     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01267-10     Document Type: Article

References (27)

1. Al-Nawas, B., and M. Maeurer. 2008. Severe versus local odontogenic bacterial infections: comparison of microbial isolates. Eur. Surg. Res. 40:220-224.
2. Al-Nawas, B., et al. 2009. Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study. Eur. J. Clin. Microbiol. Infect. Dis. 28:75-82.
3. Baxter, R., G. T. Ray, and B. H. Fireman. 2008. Case-control study of antibiotic use and subsequent Clostridium difficile-associated diarrhea in hospitalized patients. Infect. Control Hosp. Epidemiol. 9:44-50.
4. Breivik, E. K., G. A. Björnsson, and E. Skovlund. 2000. A comparison of pain rating scales by sampling from clinical trial data. Clin. J. Pain 16:22-28. (Pubitemid 30155392)
5. Brennan, M. T., et al. 2006. Odontogenic signs and symptoms as predictors of odontogenic infection. A clinical trial. J. Am. Dent. Assoc. 137:62-66.
6. Cachovan, G., et al. 2009. Penetration of moxifloxacin into rat mandibular bone and soft tissue. Acta Odontol. Scand. 67:182-186.
7. Cachovan, G., et al. 2008. Efficacy and tolerability of moxifloxacin versus clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates (MOCLI Study), abstr. O83. Abstr. 18th Eur. Congr. Clin. Microbiol. Infect. Dis., Barcelona, Spain. http://registration.akm.ch/einsicht.php? XNABSTRACT-ID=67338&XNSPRACHE-ID=2&XNKONGRESS-ID=73&XNMASKEN-ID=900.
8. Chan, Y., and C.-H. Chan. 2003. Antibiotic resistance of pathogenic bacteria from odontogenic infections in Taiwan. J. Microbiol. Immunol. Infect. 36:105-110.
9. Diz Dios, P., et al. 2006. Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions. Antimicrob. Agents Chemother. 50:2996-3002.
10. Eick, S., T. Seltmann, and W. Pfister. 2004. Efficacy of antibiotics to strains of periodontopathogenic bacteria within a single species biofilm - an in vitro study. J. Clin. Periodontol. 31:376-383.
11. Esposito, S., et al. 2006. Concentration of moxifloxacin in plasma and tonsillar tissue after multiple administration in adult patients. J. Antimicrob. Chemother. 57:789-792.
12. Guentsch, A., H. Jentsch, W. Pfister, T. Hoffmann, and S. Eick. 2008. Moxifloxacin as an adjunctive antibiotic in the treatment of severe chronic periodontitis. J. Periodontol. 79:1894-1903.
13. Joukhadar, C., et al. 2003. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob. Agents Chemother. 47:3099-3103.
14. Landersdorfer, C. B., et al. 2009. Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation. Antimicrob. Agents Chemother. 53:2074-2081.
15. Limeres, J., I. Tomás, M. Álvarez, and P. Diz. 2005. Empirical antimicrobial therapy for odontogenic infections. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 100:263-264.
16. Lin, Y. T., and P. W. Lu. 2006. Retrospective study of pediatric facial cellulitis of odontogenic origin. Pediatr. Infect. Dis. 25:339-342.
17. Malangoni, M. A., J. Song, J. Herrington, S. Choudhri, and P. Pertel. 2006. Randomized controlled trial of moxifloxacin compared with piperacillin-tazobactam and amoxicillin-clavulanate for the treatment of complicated intra-abdominal infections. Ann. Surg. 244:204-211.
18. Milazzo, I., et al. 2002. Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections. Int. J. Antimicrob. Agents 20:451-456.
19. Piesold, J. U., B. Al-Nawas, J. E. Otten, and K. A. Grötz. 13 December 2010, accession date. Guidelines of the DGMKG. Odontogenic infections and abscesses. AWMF science-based guidelines for diagnostics and therapy. AWMF guideline registry no. 007/006. Association of the Scientific Medical Societies in Germany, Düsseldorf, Germany. http://www.awmf.org/leitlinien/detail/ll/ 007-006.html. (In German.)
20. Seppänen, L., A. Lauhio, C. Lindqvist, R. Suuronen, and R. Rautemaa. 2008. Analysis of systemic and local odontogenic infection complications requiring hospital care. J. Infect. 57:116-122.
21. Seppänen, L., R. Rautemaa, C. Lindqvist, and A. Lauhio. 2010. Changing clinical features of odontogenic maxillofacial infections. Clin. Oral Invest. 14:459-465.
22. Siqueira, J. F., Jr., and I. N. Rôças. 2009. The microbiota of acute apical abscesses. J. Dent. Res. 88:61-65.
23. Sobottka, I., et al. 2002. In vitro activity of moxifloxacin against bacteria isolated from odontogenic abscesses. Antimicrob. Agents Chemother. 46:4019-4021.
24. Sobottka, I., et al. 2009. Mikrobiologische Analyse der MOCLI-Studie. Infection 37(Suppl. IV):60-61.
25. Stefanopoulos, P. K., and A. E. Kolokotronis. 2004. The clinical significance of anaerobic bacteria in acute orofacial odontogenic infections. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 98:398-408.
26. Uluibau, I. C., T. Jaunay, and A. N. Goss. 2005. Severe odontogenic infections. Aust. Dent. J. 50(Suppl. 2):S74-S81.
27. Vick-Fragoso, R., et al. 2009. Efficacy and safety of sequential intravenous/oral moxifloxacin versus intravenous/oral amoxicillin/clavulanate for complicated skin and skin structure infections. Infection 37:407-417.